scispace - formally typeset
T

Todd R. Golub

Researcher at Harvard University

Publications -  454
Citations -  234100

Todd R. Golub is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Gene expression profiling. The author has an hindex of 164, co-authored 422 publications receiving 201457 citations. Previous affiliations of Todd R. Golub include Rush University Medical Center & Boston Children's Hospital.

Papers
More filters
Journal Article

Impaired microRNA processing enhances cellular transformation and tumorigenesis

TL;DR: In this paper, the authors show that global repression of miRNA maturation promotes cellular transformation and tumorigenesis in cancer cells expressing short hairpin RNAs (shRNAs) targeting three different components of the miRNA processing machinery.
Journal ArticleDOI

Initial genome sequencing and analysis of multiple myeloma

TL;DR: The massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs indicates that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.
Journal ArticleDOI

BRAF mutation predicts sensitivity to MEK inhibition

TL;DR: It is found that mutation of BRAF is associated with enhanced and selective sensitivity to MEK inhibition when compared to either ‘wild-type’ cells or cells harbouring a RAS mutation, suggesting an exquisite dependency on MEK activity in BRAF mutant tumours.
Journal ArticleDOI

Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.

TL;DR: CERES, a computational method to estimate gene-dependency levels from CRISPR–Cas9 essentiality screens while accounting for the copy number–specific effect, is developed and found that CERES decreased false-positive results and estimated sgRNA activity for both this data set and previously published screens performed with different sg RNA libraries.